CEPHALON A/S: Financial statements 2023
CVR: 20009993
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
CEPHALON A/S (CVR 20009993) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 23,862,302 and a net result of DKK 8,426,732 compared with DKK 3,787,961 the year before. That is an increase of 38.7% compared with the year before. Equity in the 2023 report amounted to DKK 23,109,480. The solvency ratio was 75.7%. The company had 15 employees in the financial year.
- Gross Profit
- DKK 23,862,302
- Profit/Loss
- DKK 8,426,732
- Equity
- DKK 23,109,480
- Total Assets
- DKK 30,508,395
- Employees
- 15
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 23.9 mio. | 8.4 mio. | 23.1 mio. | 15 |
| 2022 | - | 17.2 mio. | 3.8 mio. | 17.7 mio. | 15 |
| 2021 | - | 14.7 mio. | 2.7 mio. | 16.6 mio. | 14 |
| 2020 | - | 12.7 mio. | 1.8 mio. | 17.9 mio. | 13 |
| 2019 | - | 12.8 mio. | 684 t. | 16.7 mio. | 15 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
CEPHALON A/S has published its annual report for 2022. Gross profit came to DKK 17,204,847, and the net result was DKK 3,787,961.
About CEPHALON A/S
CEPHALON A/S is a Danish company of the type Aktieselskab based in Nørresundby, founded in 1997. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Rolf Nejsum. The board consists of Bjørn Helmer Johnsen (chair), Erling Henningsen, Klaus Erik Johansen and Rolf Nejsum. The company is owned by Scan-Med Norway AS. The company has 17 employees (2026). In 2025, the company reported a gross profit of DKK 17,447,383 and a net result of DKK 3,261,402 compared with DKK 4,276,740 the year before. Equity in the 2025 report amounted to DKK 20,647,622.